Corrigendum to: "People living with HIV who have poor immune status are a key population for SARS-CoV-2 prevention" Journal of Infection, Volume 88, Issue 3, March 2024, 106122
1 Guangxi Key Laboratory of AIDS Prevention and Treatment & School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi, China; Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning 530021, Guangxi, China.
2 Guangxi Key Laboratory of AIDS Prevention and Treatment & School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi, China; Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning 530021, Guangxi, China; The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, Guangxi, China.
3 AIDS Clinical Treatment Center of Guangxi (Nanning) & The Fourth People's Hospital of Nanning, Nanning 530012, Guangxi, China.
4 Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning 530021, Guangxi, China; Life Science Institute, Guangxi Medical University, Nanning 530021, Guangxi, China.
5 Guangxi Key Laboratory of AIDS Prevention and Treatment & School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi, China; Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning 530021, Guangxi, China; Life Science Institute, Guangxi Medical University, Nanning 530021, Guangxi, China.
6 AIDS Clinical Treatment Center of Guangxi (Nanning) & The Fourth People's Hospital of Nanning, Nanning 530012, Guangxi, China. Electronic address: 20060830xzm@163.com.